Live
CellThe critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBMFierceBiotechPE firm Altaris scoops up AI drug development outfit Simulations Plus for $375MBioPharma DiveLilly buys non-opioid pain drugmaker 4EBioPharma DiveExpress Scripts, PCMA sue to block Tennesee law breaking up PBMs and pharmaciesBioWorldChinese challenger Gan & Lee gains momentum in metabolic diseaseBioWorldElixiron’s enrupatinib shows upbeat interim phase II AD resultsBioWorldChina partnerships drive biopharma’s biggest deal month since 2023BioWorldOricell brings first pivotal-stage CAR T in liver cancerBioWorldLaekna licenses LAE-118 ex-China to Vasque in $527M dealBioPharma DiveFDA staff scrutinizes evidence supporting Moderna’s flu vaccineEndpoints NewsEdgewise to advance heart drug into Phase 3 following mid-stage data updateFierceBiotechEdgewise data power rival to BMS and Cytokinetics toward phase 3
Endpoints News Mar 17, 2026

China mRNA therapy startup Innorna to test gout treatment in US

China mRNA therapy startup Innorna to test gout treatment in US

Original
Body unavailable. Use the original source.